Elizabeth A. Olek
Directeur Technique/Scientifique/R&D chez KRONOS BIO, INC.
Fortune : 189 410 $ au 30/04/2024
Provenance du réseau au premier degré de Elizabeth A. Olek
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.
43
| Subsidiary | Pharmaceuticals: Major | 43 |
| Public Company | Pharmaceuticals: Major | 23 | |
| Subsidiary | Biotechnology | 19 | |
| Subsidiary | Pharmaceuticals: Major | 15 | |
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The company is based in Cambridge, MA.
9
| Subsidiary | Miscellaneous Commercial Services | 9 |
| Subsidiary | Pharmaceuticals: Major | 8 | |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Elizabeth A. Olek via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Human Resources Officer Public Communications Contact | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Operating Officer General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Investor Relations Contact Chief Operating Officer | |
| BAYER AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| XOMA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Corporate Officer/Principal Public Communications Contact | |
| ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
CoTherix, Inc.
 CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Director of Finance/CFO President Corporate Officer/Principal Director of Finance/CFO | |
| ACCELERON PHARMA INC. | Biotechnology | Director/Board Member Founder Corporate Officer/Principal | |
| MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Tech/Sci/R&D Officer | |
| RADIUS HEALTH, INC. | Biotechnology | Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Compliance Officer | |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Investment Managers | Founder Founder Chairman | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Consultant / Advisor | |
| Stanford University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| MERRIMACK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| Emory University | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Masters Business Admin Undergraduate Degree Graduate Degree Undergraduate Degree Doctorate Degree | |
| The California State University | College/University | Graduate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Graduate Degree Masters Business Admin Graduate Degree | |
| University of California, Davis | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Founder Private Equity Investor | |
| Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal General Counsel | ||
| ARNO THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Founder Chairman | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| KITE PHARMA INC | Biotechnology | Founder Founder Chief Executive Officer | |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | Drugstore Chains | Chief Executive Officer Chairman Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Founder Founder Consultant / Advisor | |
| ALLOGENE THERAPEUTICS, INC. | Biotechnology | Founder Founder Founder | |
| TYRA BIOSCIENCES, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| BIOMX INC. | Biotechnology | Director/Board Member Director/Board Member | |
Treeline Biosciences, Inc.
 Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | Biotechnology | Director/Board Member Director/Board Member Founder Corporate Officer/Principal | |
76bio, Inc.
 76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation. | Pharmaceuticals: Major | Founder Founder Founder | |
| CAPRICOR THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Secretary Director/Board Member Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 48 |
| Allemagne | 2 |
| Suisse | 2 |
| Israël | 2 |
Sectorielle
| Health Technology | 32 |
| Consumer Services | 12 |
| Finance | 6 |
| Commercial Services | 2 |
| Retail Trade | 2 |
Opérationnelle
| Director/Board Member | 536 |
| Corporate Officer/Principal | 278 |
| Independent Dir/Board Member | 168 |
| Chairman | 108 |
| Chief Tech/Sci/R&D Officer | 93 |
Relations les plus connectées
| Insiders | |
|---|---|
| Joshua Kazam | 43 |
| Arie Belldegrun | 42 |
| Steven Elms | 37 |
| Otello Stampacchia | 37 |
| Nicholas Simon | 33 |
| Thomas Ebeling | 33 |
| Michael Grey | 32 |
| William Ringo | 32 |
| Nicole Vitullo | 28 |
| Lori Kunkel | 27 |
| Mark Iwicki | 26 |
| Thomas Paul Koestler | 26 |
| Leonard Patrick Gage | 26 |
| Gary E. Frashier | 26 |
| David Tanen | 25 |
- Bourse
- Insiders
- Elizabeth A. Olek
- Connexions Sociétés